Pancreatic neuroendocrine tumors (pNETs) are rare and part of the diverse family of
neuroendocrine neoplasms (NENs). Somatostatin receptors (SSTRs), which are widely …

Background The optimal surgical strategy for pancreatic neuroendocrine tumors (PNETs) is
unknown. However, current guidelines recommend a watch-and-wait strategy for small …

This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic
neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working …

Introduction: Recent advances in diagnostic modalities and therapeutic agents have raised
the importance of prognostic factors in predicting overall survival, as well as predictive …

Introduction: The combined use of 68gallium (68Ga)-DOTA-peptides and 18fluorine-fluoro-2-
deoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) …

The vast majority of new pNET diagnoses consist of incidentally discovered lesions on cross-
sectional imaging. The biologic behavior of pNETs is defined by the grade and stage of the …

Objective: To determine the prognostic role of metastatic lymph node (LN) number and the
minimal number of LNs for optimal staging of patients with pancreatic neuroendocrine …

Abstract Background Pancreatic neuroendocrine neoplasms (PanNENs) are a
heterogeneous group of tumors. Although the prognosis of resected PanNENs is generally …

Neuroendocrine tumours of the pancreas (pNET) are rare, accounting for 1–2% of all
pancreatic neoplasms. They develop from pancreatic islet cells and cover a wide range of …

Background The role of portal vein resection for pancreatic cancer is well established but not
for pancreatic neuroendocrine neoplasms. Evidence from studies providing information on …